Lifeward (LFWD) Change in Account Payables (2015 - 2026)
Lifeward (LFWD) reported Change in Account Payables of $1.2 million for Q1 2026, up 252.36% on a YoY basis from $348509.9 in Q1 2025, and up 2712.77% sequentially from -$47000.0 in Q4 2025.
Lifeward (LFWD) Change in Account Payables (2015 - 2026) Analysis & Trends
Lifeward (LFWD) has 12 years of Change in Account Payables data on file, last reported at $1.2 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Account Payables rose 252.36% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 2820.97% YoY), and the FY2025 full-year result was -$347000.0, down 638.3% from the prior year.
- Change in Account Payables advanced to $1.2 million in Q1 2026, from -$47000.0 in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $1.4 million in Q2 2025 to a low of -$867000.0 in Q3 2025.
- A 5-year average of $143352.9 and a median of $81000.0 in 2022 frame the typical range for Change in Account Payables.
- Across the five-year window, Change in Account Payables soared 896.55% in 2023 and tumbled 3539.13% in 2024, its largest moves.
- Tracing LFWD's Change in Account Payables over 5 years: stood at $42000.0 in 2022, then slumped by 2142.86% to -$858000.0 in 2023, then soared by 103.5% to $30000.0 in 2024, then tumbled by 256.67% to -$47000.0 in 2025, then jumped by 2712.77% to $1.2 million in 2026.
- Business Quant data shows LFWD's Change in Account Payables at $1.2 million in Q1 2026, -$47000.0 in Q4 2025, and -$867000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lifeward | 8.16 Mn | -3.26 Mn | 1.34 Mn | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.23 Mn |
| Mar 31, 2026 | 1.23 Mn |
| Dec 31, 2025 | -47,000.00 |
| Dec 31, 2025 | -47,000.00 |
| Sep 30, 2025 | -867,000.00 |
| Sep 30, 2025 | -867,000.00 |
| Jun 30, 2025 | 1.37 Mn |
| Jun 30, 2025 | 1.37 Mn |
| Mar 31, 2025 | -806,000.00 |
| Mar 31, 2025 | -806,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Dec 31, 2024 | 30,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Sep 30, 2024 | 143,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Jun 30, 2024 | 571,000.00 |
| Mar 31, 2024 | -791,000.00 |
| Mar 31, 2024 | -791,000.00 |
| Dec 31, 2023 | -858,000.00 |
| Dec 31, 2023 | -858,000.00 |